Smart watch boosts CPAP use in sleep apnea patients
NCT ID NCT05530265
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether wearing a smart watch and using a health app could help people with obstructive sleep apnea use their CPAP machine more regularly. 46 adults who either had never used CPAP or used it less than 4 hours a night were given a smart watch and app for 90 days. The goal was to see if the extra health tracking and feedback improved how often and how long they used the CPAP.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- smart watch and health app
- What this could lead to
- If it works, this could give doctors a simple, non-drug way to help people stick with CPAP therapy and get better sleep.
- What could go wrong
- This is a small, completed trial with only 46 participants, so results may not apply to everyone. The effect may be small or not last beyond 90 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
46 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosed with OSA (apnea-hyponea index \[AHI\])≥ 5 /h) by type 1 polysomnography * no prior use of PAP (CPAP or auto-adjusting PAP \[APAP\]), or no prior use of PAP within the previous 90 days in patients who had received PAP therapy, or current PAP users with average daily usage (all days) \< 4 hours within the previous 90 days Exclusion Criteria: * patients who refuse PAP therapy * patients who have used a smart watch (e.g., Galaxy Watch, Apple Watch, etc.) within the previous 90 days * patients with central sleep apnea or neuromuscular disease * patients receiving supplemental oxygen therapy due to underlying diseases including heart failure, stroke, chronic obstructive pulmonary disease, interstitial pulmonary disease, hypoventilation syndrome, or whose baseline oxygen saturation is less than 90% * patients with implanted cardiac pacemakers, defibrillators, or other electronic devices * patients who are inexperienced in using smartphones, apps, or smart watches * patients with an inability or unwillingness to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Adherence, treatment are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartwatch predict which cancer patients return to hospital?
- Can peer mentors help stop HIV transmission from mother to child?
- New digital rehab could bring heart recovery to your living room
- New food guide aims to help kids with celiac eat better
- Brain blood flow may hold key to sleep apnea breathing stability
- Digital pill and app help At-Risk men stay on track with HIV prevention